P R Murray

796 total citations · 1 hit paper
15 papers, 642 citations indexed

About

P R Murray is a scholar working on Clinical Biochemistry, Infectious Diseases and Pharmacology. According to data from OpenAlex, P R Murray has authored 15 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Clinical Biochemistry, 5 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in P R Murray's work include Bacterial Identification and Susceptibility Testing (9 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antibiotic Resistance in Bacteria (4 papers). P R Murray is often cited by papers focused on Bacterial Identification and Susceptibility Testing (9 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antibiotic Resistance in Bacteria (4 papers). P R Murray collaborates with scholars based in United States and United Kingdom. P R Murray's co-authors include Jessica C. Kissinger, R. J. Mulder, D.F. Sahm, Michael S. Gilmore, A C Niles, Leonid Heifets, John A. Washington, Henry D. Isenberg, S D Allen and R F D'Amato and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and European Journal of Epidemiology.

In The Last Decade

P R Murray

14 papers receiving 601 citations

Hit Papers

In vitro susceptibility studies of vancomycin-resistant E... 1989 2026 2001 2013 1989 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
    1989 420 citations D.F. Sahm, Jessica C. Kissinger et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P R Murray United States 11 374 184 178 166 96 15 642
Gilda de Cespédès France 15 270 0.7× 93 0.5× 160 0.9× 114 0.7× 85 0.9× 16 481
H. Talsania United Kingdom 11 200 0.5× 153 0.8× 142 0.8× 95 0.6× 39 0.4× 15 435
Louis Garry France 16 344 0.9× 148 0.8× 175 1.0× 183 1.1× 54 0.6× 31 769
Carmen Ponte Spain 17 261 0.7× 198 1.1× 190 1.1× 361 2.2× 48 0.5× 47 922
Pascal Vannuffel Belgium 13 561 1.5× 257 1.4× 453 2.5× 424 2.6× 60 0.6× 17 1.1k
T Horaud France 21 588 1.6× 217 1.2× 287 1.6× 264 1.6× 143 1.5× 36 992
R F D'Amato United States 15 322 0.9× 83 0.5× 103 0.6× 368 2.2× 54 0.6× 38 785
A P Kuritza United States 11 201 0.5× 139 0.8× 95 0.5× 73 0.4× 80 0.8× 14 487
Ritsuko Mitsuhata Japan 8 328 0.9× 168 0.9× 253 1.4× 111 0.7× 82 0.9× 13 562
Mary E. Stemper United States 18 494 1.3× 214 1.2× 313 1.8× 165 1.0× 77 0.8× 27 933

Countries citing papers authored by P R Murray

Since Specialization
Citations

This map shows the geographic impact of P R Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P R Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P R Murray more than expected).

Fields of papers citing papers by P R Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P R Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P R Murray. The network helps show where P R Murray may publish in the future.

Co-authorship network of co-authors of P R Murray

This figure shows the co-authorship network connecting the top 25 collaborators of P R Murray. A scholar is included among the top collaborators of P R Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P R Murray. P R Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wexler, Hannah M., E Molitoris, P R Murray, et al.. (1996). Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation. Journal of Clinical Microbiology. 34(1). 170–174. 21 indexed citations
2.
Pfaller, Michael A., A L Barry, L. D. Sabath, et al.. (1993). In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers. European Journal of Epidemiology. 9(6). 658–62. 4 indexed citations
3.
Washington, John A., Ronald N. Jones, E. Gerlach, et al.. (1993). Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime. Antimicrobial Agents and Chemotherapy. 37(8). 1696–1700. 37 indexed citations
4.
Washington, John A., Ronald N. Jones, S D Allen, et al.. (1991). In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates. Antimicrobial Agents and Chemotherapy. 35(7). 1508–1511. 7 indexed citations
5.
Murray, P R. (1991). Antimicrobial activity of seven oral antibiotics against selected community- and hospital-acquired pathogens.. PubMed. 13(2). 224–31. 10 indexed citations
6.
Isenberg, Henry D., R F D'Amato, Leonid Heifets, et al.. (1991). Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteria. Journal of Clinical Microbiology. 29(8). 1719–1722. 59 indexed citations
7.
Sahm, D.F., et al.. (1989). In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrobial Agents and Chemotherapy. 33(9). 1588–1591. 420 indexed citations breakdown →
8.
Niles, A C, et al.. (1987). Effect of calcium on in vitro activity of LY146032 against Clostridium difficile. Antimicrobial Agents and Chemotherapy. 31(3). 461–462. 12 indexed citations
9.
Pfaller, Michael A., A C Niles, & P R Murray. (1984). In vitro antibacterial activity of cefpiramide. Antimicrobial Agents and Chemotherapy. 25(3). 368–372. 15 indexed citations
10.
Murray, P R & A C Niles. (1983). Inoculum preparation for anaerobic susceptibility tests. Journal of Clinical Microbiology. 18(3). 733–734. 10 indexed citations
11.
Murray, P R & Donald J. Krogstad. (1981). Preliminary identification of mycobacteria isolated from clinical specimens. Journal of Clinical Microbiology. 13(3). 468–471. 1 indexed citations
12.
Murray, P R & Cheri M. Hampton. (1980). Recovery of pathogenic bacteria from cerebrospinal fluid. Journal of Clinical Microbiology. 12(4). 554–557. 11 indexed citations
13.
Nahm, Moon H., P R Murray, B L Clevinger, & Joseph M. Davie. (1980). Improved diagnostic accuracy using monoclonal antibody group A streptococcal carbohydrate. Journal of Clinical Microbiology. 12(4). 506–508. 11 indexed citations
14.
Murray, P R, et al.. (1979). Relative recovery of anaerobes on different isolation media. Journal of Clinical Microbiology. 10(5). 756–757. 10 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilda de Cespédès Breakdown of academic impact, for papers by H. Talsania Breakdown of academic impact, for papers by Louis Garry Breakdown of academic impact, for papers by Carmen Ponte Breakdown of academic impact, for papers by Pascal Vannuffel Breakdown of academic impact, for papers by T Horaud Breakdown of academic impact, for papers by R F D'Amato Breakdown of academic impact, for papers by A P Kuritza Breakdown of academic impact, for papers by Ritsuko Mitsuhata Breakdown of academic impact, for papers by Mary E. Stemper
Rankless by CCL
2026